Network pharmacology study of Tibetan medicine Corydalis Herba against acute myocardial ischemia.
10.19540/j.cnki.cjcmm.20210129.401
- Author:
Xiao-Chun ZHOU
1
;
Mei-Wen HUANG
1
;
Shun-Gang JIAO
1
;
Fu-Xing GE
1
;
Pan-Long CHEN
1
;
Chang-Xin LIU
1
;
Xiao-Li GAO
1
;
Peng-Fei TU
1
;
Xing-Yun CHAI
1
Author Information
1. Modern Research Center for Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 100029, China.
- Publication Type:Journal Article
- Keywords:
Corydalis Herba;
acute myocardial ischemia;
mechanism of action;
medicinal substances;
molecular docking;
network pharmacology
- MeSH:
Corydalis;
Drugs, Chinese Herbal/pharmacology*;
Medicine, Tibetan Traditional;
Molecular Docking Simulation;
Myocardial Ischemia/drug therapy*;
Vascular Endothelial Growth Factor A
- From:
China Journal of Chinese Materia Medica
2021;46(12):3058-3065
- CountryChina
- Language:Chinese
-
Abstract:
In this study, the compound search was completed through SciFinder and CNKI databases, and the drug-like properties were screened in FAFdrugs4 and SEA Search Server databases. In addition, based on the target sets related to acute myocardial ischemia(AMI) searched in disease target databases such as OMIM database, GeneCards database and DrugBank, a network diagram of chemical component-target-pathway-disease was established via Cytoscape to predict the potential active components of Corydalis Herba, a traditional Tibetan herbal medicine which derived from the aerial parts of Corydalis hendersonii and C. mucronifera against AMI. A protein-protein interaction(PPI) network was constructed through the STRING database and the core targets in the network were predicted. And the enrichment analyses of core targets were completed by DAVID database and R software. Furthermore, a molecular docking method was used to verify the binding of the components with core targets using softwares such as Autodock Vina. The present results showed that there were 60 compounds related to AMI in Corydalis Herba, involving 73 potential targets. The GO functional enrichment analysis obtained 282 biological processes(BP), 49 cell components(CC) and 78 molecular functions(MF). KEGG was enriched into 85 pathways, including alcoholism pathway, endocrine resistance pathway, calcium signaling pathway, cAMP signaling pathway, vascular endothelial growth factor signaling pathway and adrenergic signaling transduction pathway of myocardial cells. The results of network topology analysis showed that the key components of anti-AMI of Corydalis Herba might be tetrahydropalmatine, etrahydrocolumbamine, N-trans-feruloyloctopamine, N-cis-p-coumaroyloctopamine, N-trans-p-coumaroylnoradrenline and N-trans-p-coumaroyloctopamine, and their core targets might be CDH23, SCN4 B and NFASC. The results of molecular docking showed that the key components of Corydalis Herba had stable binding activity with the core targets. This study provides reference for further elucidation of the pharmacological effects of Corydalis Herba against AMI, subsequent clinical application, and development.
